Detalhe da pesquisa
1.
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic Acid.
J Assoc Physicians India
; 70(9): 11-12, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082889
2.
Appropriate use of PCSK9 Inhibitors in India.
J Assoc Physicians India
; 67(4): 74-85, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31311223
3.
Association of Physicians of India: Position Statement on Role of Chirally Pure Molecules in Clinical Practice.
J Assoc Physicians India
; 65(12): 49-60, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327523
4.
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2020: Part III.
J Assoc Physicians India
; 68(11[Special]): 8-9, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350610
5.
Lifestyle Modification in the Prevention of Atherosclerotic Cardiovascular Disease.
J Assoc Physicians India
; 68(11[Special]): 10-20, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350611
6.
Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
J Assoc Physicians India
; 68(11[Special]): 21-34, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350612
7.
High Sensitivity C-Reactive Protein.
J Assoc Physicians India
; 68(11[Special]): 47-49, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350615
8.
Lipoprotein(a) and ASCVD risk.
J Assoc Physicians India
; 68(11[Special]): 42-46, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350614
9.
Apolipoprotein B as a Predictor of CVD.
J Assoc Physicians India
; 68(11[Special]): 50-53, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350616
10.
Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.
J Assoc Physicians India
; 68(11[Special]): 54-58, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350617
11.
Triglycerides and Atherosclerotic Cardiovascular Disease.
J Assoc Physicians India
; 68(11[Special]): 35-41, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350613
12.
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.
J Clin Lipidol
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485619
13.
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India.
J Clin Lipidol
; 17(2): e1-e14, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577628
14.
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India.
J Clin Lipidol
; 16(3): 261-271, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508456
15.
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1.
J Assoc Physicians India
; 64(3 suppl): 7-52, 2016 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28762263
16.
Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study.
J Family Med Prim Care
; 9(8): 4156-4164, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110825
17.
Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022.
Hypertens Res
; 46(1): 3-8, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229522
18.
Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases.
Hypertens Res
; 45(1): 1-2, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750504
19.
Presence of elevated non-HDL among patients with T2DM with CV events despite of optimal LDL-C - A report from South India.
Indian Heart J
; 68(3): 378-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27316499
20.
Cystic fibrosis in one family.
J Assoc Physicians India
; 41(2): 111-2, 1993 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-8335600